Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial.

Michael P BokochAmy T TranErika L BrinsonSivan G MarcusMeghana ReddyElizabeth SunGarrett R RollManuel PardoScott FieldsDieter AdelmannRishi P KothariMatthieu Legrand

Published in: BMJ open (2023)

ClinicalTrials.govNCT04901169.

Keyphrases

double blind
angiotensin ii
placebo controlled
clinical trial
angiotensin converting enzyme
vascular smooth muscle cells
randomized controlled trial
phase iii
study protocol
phase ii